GRM1 and melanoma: Notably, the loss of only one Sox10 allele is sufficient to counteract the activity of oncogenes, such as Nras and Grm1, and to prevent melanoma in transgenic murine melanoma models (Cronin et al., 2013; Shakhova et al., 2012).